0
0

Department of Veterans Affairs Awarded a Contract to TAKEDA PHARMACEUTICALS AMERICA INC for $36,984.28

Signed on

8/24/2025, 12:00 AM

TAKEDA PHARMACEUTICALS AMERICA INC Government Contract #36C24525N0930

TAKEDA PHARMACEUTICALS AMERICA INC was awarded a contract with the United States Government for $36,984.28. The contract was awarded by the agency office 245-NETWORK CONTRACT OFFICE 5 (36C245), which is a division with the Department of Veterans Affairs within the Department of Veterans Affairs.

Summary of Award

The recipient of the federal contract is Takeda Pharmaceuticals America Inc, a U.S.-owned business that specializes in pharmaceutical manufacturing. The contract, funded by the Department of Veterans Affairs, is for TAKHZYRO 150 MG and is worth $36,984.28. The contract was awarded through full and open competition, with a single offer received. The notable transaction from the list shows the amount of $36,984.28 awarded to Takeda Pharmaceuticals America Inc on August 24, 2025.

Contract Details

Contract ID36C24525N0930
Contract TypeC
Total Obligation$36,984.28
Exercised Options$36,984.28
Base Amount + Options$36,984.28
Date Signed2025-08-24
Contract DescriptionTAKHZYRO 150 MG
Start Date2025-08-24
End Date2025-08-27

Agency Details

Awarding AgencyDepartment of Veterans Affairs
Awarding Sub AgencyDepartment of Veterans Affairs
Awarding Office245-NETWORK CONTRACT OFFICE 5 (36C245)
Funding AgencyDepartment of Veterans Affairs
Funding Sub AgencyDepartment of Veterans Affairs
Funding Office512-BALTIMORE(00512)(36C512)

Recipient Details

RecipientTAKEDA PHARMACEUTICALS AMERICA INC
Recipient Location1 TAKEDA PARKWAY DEERFIELD ILLINOIS, UNITED STATES
Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Manufacturer of Goods, Not Designated a Small Business, Special Designations, U.S.-Owned Business

Comments

Award Transactions

Transaction #0$36,984.28August 24, 2025

Department of Veterans Affairs, a sub agency of Department of Veterans Affairs, issued a payment of $36,984.28 to TAKEDA PHARMACEUTICALS AMERICA INC. The payment included a Subsidy Cost of $0.00.